Mednax, Inc. (MD)
Q2 2012 Earnings Call
July 31, 2012 10:00 a.m. ET
David Parker - Vice President, Investor Relations
Roger J. Medel - Chief Executive Officer
Vivian Lopez-Blanco - Chief Financial Officer
Ryan Daniels - William Blair & Company
Kevin Ellich - Piper Jaffray Companies
Kevin Fischbeck – Bank of America Merrill Lynch
John Ransom - Raymond James
Gary Taylor – Citigroup
Ralph Giacobbe - Credit Suisse
Brooks O'Neil - Dougherty & Company
Kevin Campbell - Avondale Partners
Robert Mains - Stifel Nicolaus & Company, Inc.
Ladies and gentlemen, thank you for standing by and welcome to the Mednax Second Quarter Earnings Conference Call. (Operator instructions) As a reminder, this teleconference is being recorded.
Now, at this time I will turn the conference call over to your hose, Vice President of Investor Relations, Mr. David Parker. Please go ahead, sir.
Thank you, Tony, and, as he indicated, welcome to Mednax's 2012 second quarter earnings call.
Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on assumptions and assessments made by Mednax's management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements made during this call are made as of today and Mednax undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise.